Oxidized LDL Induces Transcription Factor Activator Protein–1 but Inhibits Activation of Nuclear Factor–κB in Human Vascular Smooth Muscle Cells
Author(s) -
Mikko P.S. Ares,
Bengt Kallin,
Per Eriksson,
Jan Nilsson
Publication year - 1995
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/01.atv.15.10.1584
Subject(s) - lysophosphatidylcholine , activator (genetics) , transcription factor , chemistry , lipopolysaccharide , nfkb1 , transcription (linguistics) , microbiology and biotechnology , medicine , biochemistry , endocrinology , biology , gene , phospholipid , linguistics , philosophy , membrane , phosphatidylcholine
Oxidized LDL (Ox-LDL) has been implicated in the development of atherosclerotic lesions, mainly due to its enhanced uptake by macrophages and its ability to alter gene expression in arterial cells. In the present study we demonstrated that Ox-LDL activates activator protein–1 (AP-1), a transcription factor generally induced by mitogenic substances. Lysophosphatidylcholine, which is generated during oxidation of LDL, stimulated AP-1 in a dose-dependent manner. In contrast, the radical-dependent transcription factor nuclear factor–κB (NF-κB) was not activated by Ox-LDL, and at a concentration of 50 μg/mL, Ox-LDL inhibited lipopolysaccharide-induced activation of NF-κB. Oxysterols but not lysophosphatidylcholine inhibited lipopolysaccharide-induced NF-κB activation, suggesting that they may be responsible for the inhibitory effect of Ox-LDL. In conclusion, Ox-LDL has opposing effects on the activities of NF-κB and AP-1, suggesting involvement of mechanisms for transcriptional regulation that are strongly affected by lipid oxidation products.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom